OSE Immunotherapeutics Publishes New Data on FR104, CD28 … – Business Wire (press release)
|
OSE Immunotherapeutics Publishes New Data on FR104, CD28 …
Business Wire (press release) OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) (Paris:OSE), today announces the positive results of two preclinical studies evaluating … |
